ACE and aortic stenosis: Therefore, RAAS inhibitors such as angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin II receptor blockers (ARBs) might reduce the burden of LV pressure in AS patients, which will have a favorable impact on LV remodeling to reduce hypertrophy and fibrosis (4).